Information Provided By: 
Fly News Breaks for March 13, 2018
MYGN
Mar 13, 2018 | 11:13 EDT
Piper Jaffray analyst William Quirk believes the subpoena Myriad received from the Health & Human Services Office of the Inspector General is due to one of two issues. First, Myriad performed tests on inappropriate patients, or second, Myriad billed incorrectly.Quirk sees little risk around the first option, but said the second could be more concerning. Regardless of which it is, the analyst said Myriad shares will likely be range-bound until the resolution of the subpoena, and maintained a Neutral rating on Myriad shares.
News For MYGN From the Last 2 Days
There are no results for your query MYGN
